Dr. Reddy's Laboratories Files Routine 6-K
Ticker: RDY · Form: 6-K · Filed: Nov 26, 2024 · CIK: 1135951
Sentiment: neutral
Topics: sec-filing, routine-report, foreign-private-issuer
TL;DR
DRL filed a 6-K, nothing major to see here.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on November 26, 2024, to report information as a foreign private issuer. The filing does not contain specific financial figures or material events beyond its routine reporting status.
Why It Matters
This filing indicates Dr. Reddy's is fulfilling its ongoing reporting obligations as a foreign private issuer with the SEC, which is standard practice.
Risk Assessment
Risk Level: low — The filing is a routine report and does not disclose any new material risks or significant events.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 0001575872-24-001203 (filing_id) — Accession Number
- 20241126 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating routine reporting by Dr. Reddy's Laboratories Ltd.
When was this Form 6-K filed?
The filing was made on November 26, 2024.
Does Dr. Reddy's Laboratories file annual reports under Form 20-F or 40-F?
Yes, Dr. Reddy's Laboratories indicates it files annual reports under cover of Form 20-F.
What is the principal executive office address for Dr. Reddy's Laboratories?
The principal executive office is located at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Does this filing contain any specific financial results or material events?
Based on the provided text, this Form 6-K appears to be a routine filing and does not detail specific financial results or material events.
Filing Stats: 402 words · 2 min read · ~1 pages · Grade level 16.8 · Accepted 2024-11-26 06:08:11
Filing Documents
- drr0698_6k.htm (6-K) — 14KB
- drr0698_ex99-1.htm (EX-99.1) — 7KB
- drr0698_ex99-1img01.jpg (GRAPHIC) — 4KB
- drr0698_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-24-001203.txt ( ) — 34KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY’S LABORATORIES LIMITED (Registrant) Date: November 26, 2024 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3